Thalidomide Side Effects Were Hidden By Manufacturer: Report

The makers of the controversial morning sickness drug Thalidomide, which has been linked to thousands of birth defects worldwide, appears to have intentionally misled investigators and the public decades ago in an effort to hide the side effects associated with the controversial drug, according to German officials. 

In a report released by the German state of North-Rhine Westphalia (NRW), investigators from the University of Muenster indicate that the drug manufacturer Gruenenthal gave the medical and scientific community false information about the potential Thalidomide side effects, kept knowledge of problems associated with the drug a secret, and delayed efforts to remove the drug from the market as long as possible.

The activities happened decades ago, when the side effects of thalidomide were first suspected, according to the investigation, which was reported by Reuters.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Thalidomide was first released as a morning sickness drug in 1957. Four years later, it was removed from the market after it was determined that the thalidomide caused major birth defects when used during pregnancy. It was the first product that established medications could cross the placental barrier and cause harm to a fetus.

It is estimated that between 10,000 and 20,000 children were born worldwide with birth defects from thalidomide. It’s impact was limited in the United States because the FDA denied the drug approval, saying that it needed to be more thoroughly tested. However, the drug was given to doctors in the U.S. during its clinical testing phase and it is unclear how many children it affected.

Thalidomide is now sold under the brand name Thalomid and is used for the treatment of multiple myeloma.

In 2012, Gruenenthal officials formally apologized to those who continue to suffer birth defects due to the drug’s side effects and dedicated a statue to thalidomide victims in Stolberg, Germany.

Following the apology over the thalidomide birth defects, many victims told various media outlets that the action was insulting and did little those who were born with life-long health problems caused by the drug’s side effects.

1 Comments

  • PaulNovember 17, 2016 at 12:44 am

    Just need to know why it now haven't had any one contact me over my birth defect

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted yesterday)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted yesterday)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.